Ecoza is owned by Resilia Pharms.
Ecoza contains Econazole Nitrate.
Ecoza has a total of 1 drug patent out of which 0 drug patents have expired.
Ecoza was authorised for market use on 24 October, 2013.
Ecoza is available in aerosol, foam;topical dosage forms.
The generics of Ecoza are possible to be released after 08 August, 2031.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US10071054||RESILIA PHARMS||Econazole composition and methods of treatment therewith|| |
(8 years from now)
Drugs and Companies using ECONAZOLE NITRATE ingredient
Market Authorisation Date: 24 October, 2013
Dosage: AEROSOL, FOAM;TOPICAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic